Title: FDG Accumulation and Tumor Biology
Authors: Pauwels, E. K. J. 
Ribeiro, M. J. 
Stoot, J. H. M. B. 
McCready, V. R. 
Bourguignon, M. 
Mazière, B. 
Keywords: Scintigraphy;Fluorodeoxyglucose;Tumor biology
Issue Date: 1998
Citation: Nuclear Medicine and Biology. 25:4 (1998) 317-322
Abstract: The tumoral uptake of fluorine-18-deoxyglucose (FDG) is based upon enhanced glycolysis. Following injection, FDG is phosphorylated and trapped intracellularly. An important mechanism to transport FDG into the transformed cell is based upon the action of glucose transporter proteins; furthermore, highly active hexokinase bound to tumor mitochondria helps to trap FDG into the cell. In addition, enhanced FDG uptake may be due to relative hypoxia in tumor masses, which activates the anaerobic glycolytic pathway. In spite of these processes, FDG uptake is relatively aspecific since all living cells need glucose. Clinical use is therefore recommended in carefully selected patients.
URI: http://hdl.handle.net/10316/4860
Rights: openAccess
Appears in Collections:FMUC Medicina - Artigos em Revistas Internacionais

Files in This Item:
File Description SizeFormat 
filee75bca7ea38144cdaf3134d051016923.pdf301.56 kBAdobe PDFView/Open
Show full item record
Google ScholarTM
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.